HLVX

HLVX

USD

HilleVax Inc. Common Stock

$2.090-0.010 (-0.476%)

Preço em tempo real

Healthcare
Biotecnologia
Estados Unidos

Gráfico de preços

Nenhum dado de gráfico disponível

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$2.100

Máximo

$2.090

Mínimo

$2.090

Volume

N/A

Fundamentos da empresa

Capitalização de mercado

104.8M

Setor

Biotecnologia

País

United States

Estatísticas de negociação

Volume médio

0.69M

Bolsa de valores

NMS

Moeda

USD

Faixa de 52 semanas

Mínimo $1.34Atual $2.090Máximo $2.17

Notícias relacionadas

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

Ver mais
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

Ver mais
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)
GlobeNewswire

HilleVax Reports Second Quarter 2025 Financial Results

BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the

Ver mais
HilleVax Reports Second Quarter 2025 Financial Results
PR Newswire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the...

Ver mais
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.
PR Newswire

Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

Ver mais
Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders
GlobeNewswire

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) and XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA) announced today they have entered